IL2 and melanoma: For example, Sahin et al. observed a strong decrease in the expression of PD1, TIM3, and the exhaustion-associated transcription factor TOX in bulk CD8+ TILs in a mouse melanoma model upon monotherapy with a long-acting CD122-targeted IL-2 derivative20.